| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Veru Inc. (VERU) has 8 insiders with recent SEC Form 4 filings, including 13 buys and 3 sells. VERU is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| Dir | 100.0K | $231.0K | - | |
| CEO | 100.0K | $231.0K | - | |
| Other | 27.0K | $62.4K | - | |
| Other | 27.0K | $62.4K | - | |
| CFO | 27.0K | $62.4K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Jan 24, 2019 | Steiner Mitchell Shuster82 | President And CEO | Sell | 4,400 | $1.33 | $5,859.04 | - | |
| Jan 23, 2019 | Steiner Mitchell Shuster82 | President And CEO | Sell | 25,600 | $1.34 | $34,347.39 | -0.2% | |
| Dec 18, 2018 | Fisch Harry | Director, 10% Owner | Buy | 30,000 | $1.42 | $42,672.00 | +4.0% | |
| Dec 18, 2018 | Barnette K Gary | Chief Scientific Officer | Buy | 100,000 | $1.46 | $146,160.00 | +200.0% | |
| Sep 6, 2018 | Socorro Jesus | Director | Buy | 5,400 | $1.89 | $10,204.38 | +76.1% | |
| Sep 6, 2018 | Fisch Harry | Director, 10% Owner | Buy | 15,800 | $1.89 | $29,929.92 | +1.1% | |
| Mar 16, 2018 | Fisch Harry | Director, 10% Owner | Buy | 5,000 | $1.96 | $9,800.00 | +0.7% | |
| Mar 16, 2018 | Steiner Mitchell Shuster82 | President And CEO | Buy | 20,000 | $1.96 | $39,265.50 | +10.5% | |
| Mar 15, 2018 | Fisch Harry | Director, 10% Owner | Buy | 10,000 | $1.90 | $18,950.00 | +1.4% | |
| Mar 14, 2018 | Fisch Harry | Director, 10% Owner | Buy | 10,000 | $1.87 | $18,700.00 | +1.4% |